Antidepressant discontinuation syndromes: clinical relevance, prevention and management

PM Haddad - Drug Safety, 2001 - Springer
Discontinuation symptoms are recognised with tricyclic antidepressants, monoamine
oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs) and miscellaneous …

The SSRI discontinuation syndrome

P Haddad - Journal of psychopharmacology, 1998 - journals.sagepub.com
A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome
appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves …

The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?

E White, J Read, S Julo - Therapeutic advances in …, 2021 - journals.sagepub.com
Background: Antidepressant withdrawal is experienced by about half of people who try to
reduce or come off their medication. It can be a debilitating, long lasting process. Many …

[图书][B] Your drug may be your problem: How and why to stop taking psychiatric medications

P Breggin, D Cohen - 2007 - books.google.com
When first published in 1999, Your Drug May Be Your Problem was ahead of its time. The
only book to provide an uncensored description of the dangers involved in taking every kind …

Recognising and managing antidepressant discontinuation symptoms

PM Haddad, IM Anderson - Advances in Psychiatric Treatment, 2007 - cambridge.org
Antidepressant discontinuation symptoms occur with all classes of antidepressant. A well-
described discontinuation syndrome occurs with the selective serotonin reuptake inhibitors …

Paroxetine, Panorama and user reporting of ADRs: Consumer intelligence matters in clinical practice and post‐marketing drug surveillance

C Medawar, A Herxheimer, A Bell… - International Journal of …, 2002 - content.iospress.com
We systematically analysed two complementary samples of emails relating to patients'
problems with the popular SSRI antidepressant, paroxetine. These mainly concerned …

Selective serotonin reuptake inhibitor 'discontinuation syndrome'or withdrawal

I Massabki, E Abi-Jaoude - The British Journal of Psychiatry, 2021 - cambridge.org
Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term
'discontinuation syndrome'are not supported by evidence. Acknowledging that SSRI use can …

Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation

F Bogetto, S Bellino, RB Revello, L Patria - CNS drugs, 2002 - Springer
Objective: Many authors have reported discontinuation symptoms associated with selective
serotonin reuptake inhibitors (SSRIs). The aim of this study was to investigate the incidence …

Selective serotonin reuptake inhibitor discontinuation syndrome: a review

L Tamam, N Ozpoyraz - Advances in Therapy, 2002 - Springer
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed in the treatment of
depression and anxiety, as well as obsessive-compulsive, eating, and impulse-control …

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation

ECG Van Geffen, JG Hugtenburg, ER Heerdink… - European journal of …, 2005 - Springer
Objective Tapering of selective serotonin reuptake inhibitor (SSRI) therapy, as opposed to
abrupt discontinuation, has been recommended by several guidelines and in the literature in …